Sangamo Therapeutics, Inc. (SGMO)

Sangamo Therapeutics Revenue

In the year 2023, Sangamo Therapeutics had annual revenue of $176.23M with 58.34% growth. Revenue in the quarter ending December 31, 2023 was $2.04M, a -92.50% decrease year-over-year.

• Revenue (ttm): $176.23M
• Revenue Growth: +58.34%
• P/S Ratio: 0.60
• Revenue / Employee: $435,141
• Employees: 405
• Market Cap: 107.86M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	176.23M	64.93M	58.34%
Dec 31, 2022	111.30M	598.00K	0.54%
Dec 31, 2021	110.70M	-7.49M	-6.34%
Dec 31, 2020	118.19M	15.76M	15.39%
Dec 31, 2019	102.43M	17.98M	21.29%
Dec 31, 2018	84.45M	47.89M	130.95%
Dec 31, 2017	36.57M	17.18M	88.60%
Dec 31, 2016	19.39M	-20.15M	-50.96%
Dec 31, 2015	39.54M	-6.33M	-13.80%
Dec 31, 2014	45.87M	21.74M	90.07%
Dec 31, 2013	24.13M	2.48M	11.44%
Dec 31, 2012	21.66M	11.34M	109.86%
Dec 31, 2011	10.32M	-10.49M	-50.40%
Dec 31, 2010	20.81M	-1.38M	-6.23%
Dec 31, 2009	22.19M	6.00M	37.08%
Dec 31, 2008	16.19M	7.09M	77.91%
Dec 31, 2007	9.10M	1.21M	15.38%
Dec 31, 2006	7.89M	5.40M	217.43%
Dec 31, 2005	2.48M	1.17M	88.90%
Dec 31, 2004	1.32M	-1.26M	-49.01%
Dec 31, 2003	2.58M	-1.76M	-40.62%
Dec 31, 2002	4.34M	-542.00K	-11.10%
Dec 31, 2001	4.89M	1.45M	42.30%
Dec 31, 2000	3.43M	1.25M	57.33%
Dec 31, 1999	2.18M	144.00K	7.07%
Dec 31, 1998	2.04M	886.00K	76.91%
Dec 31, 1997	1.15M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.